Abaxis Inc (ABAX) 49.50 $ABAX
Abaxis Hurt by Dismal Q1 Results & Fierce Competition
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:32AM CDT
Abaxis' (ABAX) first-quarter fiscal 2017 results disappointed us, with the company squarely missing the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), ABAX: 49.50 (-0.90), IDXX: 114.09 (+0.93)
New Strong Sell Stocks for August 23rd
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 10:28AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
WBMD: 52.41 (+0.36), RHI: 38.50 (+0.28), ABAX: 49.50 (-0.90), MGPI: 40.59 (+0.36), CCU: 21.60 (+0.71)
New Strong Sell Stocks for August 19th
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 6:53AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
ACHC: 51.61 (+1.28), AAP: 158.57 (-0.19), ABAX: 49.50 (-0.90), AKAM: 55.33 (+0.26), CMO: 10.05 (+0.16)
Abaxis, Inc. to Present at the Canaccord Genuity 36th Annual Growth Conference
PR Newswire - Thu Aug 04, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Clint Severson, Chairman and Chief Executive Officer, will present at the Canaccord Genuity 36th Annual Growth Conference on Thursday, August 11, 2016 at 3:00 p.m. ET. The conference will be held at InterContinental Hotel in Boston, MA.
ABAX: 49.50 (-0.90)
New Strong Sell Stocks for July 29th
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:03AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
CAJ: 28.89 (+0.16), OLED: 57.43 (+0.14), ABAX: 49.50 (-0.90), BJRI: 39.66 (+0.44), HMC: 30.96 (+0.18)
Point of Care (PoC) Lipid Test Market Size & Forecast By Instruments (Brand Market Sizing: Roche Reflotron, Roche Cobas b 101, Abaxis Piccolo, Alere Cholestech LDX, Alere Afinion, Samsung LABGEO, PTS CardioChek), By Application (Hyperlipidemia, Hypertrigl
PR Newswire - Wed Jun 22, 4:33PM CDT
Global Point of care (PoC) Lipid Test market is expected to reach USD 280.02 million by 2022 according to a new report by Grand View Research Inc. Growing geriatric population base, increasing global prevalence of cardiovascular diseases, and rising healthcare awareness due to patient education are the driving forces for the PoC Lipid Test industry growth during the forecast period.
ABAX: 49.50 (-0.90)
Abaxis Global Diagnostics and AAHA Develop Preventive Care Testing Initiative
PR Newswire - Mon Jun 06, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today announced a partnership with the American Animal Hospital Association (AAHA) to develop a wellness testing initiative that is focused on improving compliance for blood diagnostic testing.
ABAX: 49.50 (-0.90)
Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:01AM CDT
On Jun 3, 2016, we issued an updated research report on Abaxis, Inc. (ABAX). The stock currently carries a Zacks Rank #4 (Sell).
ICUI: 126.98 (+1.77), ABAX: 49.50 (-0.90), LMAT: 18.35 (+0.59), NUVA: 66.74 (+0.68)
Abaxis, Inc. to Present at the Jefferies 2016 Global Healthcare Conference
PR Newswire - Wed Jun 01, 7:02AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Ross Taylor, chief financial officer, will present at the Jefferies 2016 Global Healthcare Conference on Tuesday, June 7, 2016 at 10:30 a.m. ET. The conference will be held at the Grand Hyatt in New York City.
ABAX: 49.50 (-0.90)
New Strong Sell Stocks for May 31st
Swarup Gupta - Zacks Investment Research - Tue May 31, 8:27AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
ABAX: 49.50 (-0.90), ASB: 19.81 (+0.13), AHT: 6.82 (+0.06), CIT: 36.38 (+0.10), MATX: 42.04 (+0.86)
Abaxis, Inc. to Present at the Stifel 2016 Dental & Veterinary Conference
PR Newswire - Wed May 25, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Ross Taylor, chief financial officer, will present at the Stifel 2016 Dental & Veterinary Conference on Wednesday, June 1, 2016 at 8:00 a.m. ET. The conference will be held at The Peninsula Hotel in New York City.
ABAX: 49.50 (-0.90)
Abaxis (ABAX) Posts Solid Q4 amid International Headwind
Zacks Equity Research - Zacks Investment Research - Wed May 25, 5:28AM CDT
On May 18, 2016, we issued an updated research report on Abaxis, Inc. (ABAX).
ICUI: 126.98 (+1.77), ABAX: 49.50 (-0.90), LMAT: 18.35 (+0.59), NUVA: 66.74 (+0.68)
New Strong Sell Stocks for May 12th
Zacks Equity Research - Zacks Investment Research - Thu May 12, 6:59AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
ABC: 87.44 (+0.29), ABAX: 49.50 (-0.90), AMID: 14.28 (+0.66), ABBV: 64.12 (+0.09), FCCY: 12.77 (-0.47)
Global Biochip Market Worth USD 18.4 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: 3Qbd, Abaxis Inc, Emulate Inc - Research and Markets
BusinessWire - Thu May 05, 4:36AM CDT
Research and Markets has announced the addition of the "Global Biochip Markets: Microarrays and Lab-on-a-Chip" report to their offering.
ABAX: 49.50 (-0.90)
Abaxis (ABAX) Q4 Earnings Beat Estimates; Dividend Raised
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 9:21AM CDT
Abaxis, Inc. (ABAX) reported fourth-quarter fiscal 2016 earnings per share (EPS) of 36 cents from continuing operations.
BSX: 24.26 (-0.07), CAPR: 3.80 (+0.16), CSII: 24.69 (+0.24), ABAX: 49.50 (-0.90)
Abaxis tops Street 4Q forecasts
Automated Insights - Thu Apr 28, 4:49PM CDT
UNION CITY, Calif. (AP) _ Abaxis Inc. (ABAX) on Thursday reported fiscal fourth-quarter earnings of $8.9 million.
ABAX: 49.50 (-0.90)
Abaxis Hurt by Dismal Q1 Results & Fierce Competition
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:32AM CDT
Abaxis' (ABAX) first-quarter fiscal 2017 results disappointed us, with the company squarely missing the Zacks Consensus Estimate.
BABY: 40.64 (+0.93), MASI: 59.90 (+0.47), ABAX: 49.50 (-0.90), IDXX: 114.09 (+0.93)
New Strong Sell Stocks for August 23rd
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 10:28AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
WBMD: 52.41 (+0.36), RHI: 38.50 (+0.28), ABAX: 49.50 (-0.90), MGPI: 40.59 (+0.36), CCU: 21.60 (+0.71)
New Strong Sell Stocks for August 19th
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 6:53AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
ACHC: 51.61 (+1.28), AAP: 158.57 (-0.19), ABAX: 49.50 (-0.90), AKAM: 55.33 (+0.26), CMO: 10.05 (+0.16)
Abaxis, Inc. to Present at the Canaccord Genuity 36th Annual Growth Conference
PR Newswire - Thu Aug 04, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Clint Severson, Chairman and Chief Executive Officer, will present at the Canaccord Genuity 36th Annual Growth Conference on Thursday, August 11, 2016 at 3:00 p.m. ET. The conference will be held at InterContinental Hotel in Boston, MA.
ABAX: 49.50 (-0.90)
New Strong Sell Stocks for July 29th
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:03AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
CAJ: 28.89 (+0.16), OLED: 57.43 (+0.14), ABAX: 49.50 (-0.90), BJRI: 39.66 (+0.44), HMC: 30.96 (+0.18)
Point of Care (PoC) Lipid Test Market Size & Forecast By Instruments (Brand Market Sizing: Roche Reflotron, Roche Cobas b 101, Abaxis Piccolo, Alere Cholestech LDX, Alere Afinion, Samsung LABGEO, PTS CardioChek), By Application (Hyperlipidemia, Hypertrigl
PR Newswire - Wed Jun 22, 4:33PM CDT
Global Point of care (PoC) Lipid Test market is expected to reach USD 280.02 million by 2022 according to a new report by Grand View Research Inc. Growing geriatric population base, increasing global prevalence of cardiovascular diseases, and rising healthcare awareness due to patient education are the driving forces for the PoC Lipid Test industry growth during the forecast period.
ABAX: 49.50 (-0.90)
Abaxis Global Diagnostics and AAHA Develop Preventive Care Testing Initiative
PR Newswire - Mon Jun 06, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today announced a partnership with the American Animal Hospital Association (AAHA) to develop a wellness testing initiative that is focused on improving compliance for blood diagnostic testing.
ABAX: 49.50 (-0.90)
Abaxis (ABAX): Solid Veterinary Show Despite Global Hiccups
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 5:01AM CDT
On Jun 3, 2016, we issued an updated research report on Abaxis, Inc. (ABAX). The stock currently carries a Zacks Rank #4 (Sell).
ICUI: 126.98 (+1.77), ABAX: 49.50 (-0.90), LMAT: 18.35 (+0.59), NUVA: 66.74 (+0.68)
Abaxis, Inc. to Present at the Jefferies 2016 Global Healthcare Conference
PR Newswire - Wed Jun 01, 7:02AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Ross Taylor, chief financial officer, will present at the Jefferies 2016 Global Healthcare Conference on Tuesday, June 7, 2016 at 10:30 a.m. ET. The conference will be held at the Grand Hyatt in New York City.
ABAX: 49.50 (-0.90)
New Strong Sell Stocks for May 31st
Swarup Gupta - Zacks Investment Research - Tue May 31, 8:27AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday
ABAX: 49.50 (-0.90), ASB: 19.81 (+0.13), AHT: 6.82 (+0.06), CIT: 36.38 (+0.10), MATX: 42.04 (+0.86)
Abaxis, Inc. to Present at the Stifel 2016 Dental & Veterinary Conference
PR Newswire - Wed May 25, 7:00AM CDT
Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, announced today that Ross Taylor, chief financial officer, will present at the Stifel 2016 Dental & Veterinary Conference on Wednesday, June 1, 2016 at 8:00 a.m. ET. The conference will be held at The Peninsula Hotel in New York City.
ABAX: 49.50 (-0.90)
Abaxis (ABAX) Posts Solid Q4 amid International Headwind
Zacks Equity Research - Zacks Investment Research - Wed May 25, 5:28AM CDT
On May 18, 2016, we issued an updated research report on Abaxis, Inc. (ABAX).
ICUI: 126.98 (+1.77), ABAX: 49.50 (-0.90), LMAT: 18.35 (+0.59), NUVA: 66.74 (+0.68)
New Strong Sell Stocks for May 12th
Zacks Equity Research - Zacks Investment Research - Thu May 12, 6:59AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
ABC: 87.44 (+0.29), ABAX: 49.50 (-0.90), AMID: 14.28 (+0.66), ABBV: 64.12 (+0.09), FCCY: 12.77 (-0.47)
Global Biochip Market Worth USD 18.4 Billion by 2020 - Analysis, Technologies & Forecasts Report 2016-2020 - Key Vendors: 3Qbd, Abaxis Inc, Emulate Inc - Research and Markets
BusinessWire - Thu May 05, 4:36AM CDT
Research and Markets has announced the addition of the "Global Biochip Markets: Microarrays and Lab-on-a-Chip" report to their offering.
ABAX: 49.50 (-0.90)
Abaxis (ABAX) Q4 Earnings Beat Estimates; Dividend Raised
Zacks Equity Research - Zacks Investment Research - Fri Apr 29, 9:21AM CDT
Abaxis, Inc. (ABAX) reported fourth-quarter fiscal 2016 earnings per share (EPS) of 36 cents from continuing operations.
BSX: 24.26 (-0.07), CAPR: 3.80 (+0.16), CSII: 24.69 (+0.24), ABAX: 49.50 (-0.90)
Abaxis tops Street 4Q forecasts
Automated Insights - Thu Apr 28, 4:49PM CDT
UNION CITY, Calif. (AP) _ Abaxis Inc. (ABAX) on Thursday reported fiscal fourth-quarter earnings of $8.9 million.
ABAX: 49.50 (-0.90)
